The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Herpes zoster: A Review of Clinical Manifestations and Management
Open accessAbstract
The Varicella-zoster virus (VZV) or human herpes virus 3 is a neurotropic human alpha herpes virus responsible for chickenpox/varicella and shingles/Herpes zoster (HZ). This review will focus on HZ. Since HZ is secondary to varicella, its incidence increases with age. In children and youngsters, HZ is rare and associated to metabolic and neoplastic disorders. In adults, advanced age, distress, other infections (such as AIDS or COVID-19), and immunosuppression are the most common risk factors. HZ reactivation has recently been observed after COVID-19 vaccination. The disease shows different clinical stages of variable clinical manifestations. Some of the manifestations bear a higher risk of complications. Among the possible complications, postherpetic neuralgia, a chronic pain disease, is one of the most frequent. HZ vasculitis is associated with morbidity and mortality. Renal and gastrointestinal complications have been reported. The cornerstone of treatment is early intervention with acyclovir or brivudine. Second-line treatments are available. Pain management is essential. For (secondary) prophylaxis, currently two HZV vaccines are available for healthy older adults, a live attenuated VZV vaccine and a recombinant adjuvanted VZV glycoprotein E subunit vaccine. The latter allows vaccination also in severely immunosuppressed patients. This review focuses on manifestations of HZ and its management. Although several articles have been published on HZ, the literature continues to evolve, especially in regard to patients with comorbidities and immunocompromised patients. VZV reactivation has also emerged as an important point of discussion during the COVID-19 pandemic, especially after vaccination. The objective of this review is to discuss current updates related to clinical presentations, complications, and management of HZ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110475 · Cited by 1,027
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Beutner, K. R., Friedman, D. J., Forszpaniak, C., Andersen, P. L., & Wood, M. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1546 · Cited by 613
Molecular mechanisms of varicella zoster virus pathogenesis
Zerboni, L., Sen, N., Oliver, S. L., & Arvin, A. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3215 · Cited by 477
Herpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
LIESEGANG, T. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 471
Marzano, A. V., Genovese, G., Fabbrocini, G., Pigatto, P., Monfrecola, G., Piraccini, B. M., Veraldi, S., Rubegni, P., Cusini, M., Caputo, V., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.044 · Cited by 386
Herpes zoster: Epidemiology, natural history, and common complications
Weinberg, J. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.046 · Cited by 278
A systematic literature review of herpes zoster incidence worldwide
van Oorschot, D., Vroling, H., Bunge, E., Diaz-Decaro, J., Curran, D., & Yawn, B. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1847582 · Cited by 249
Bennett, J. L. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000768 · Cited by 209
Harbecke, R., Cohen, J. I., & Oxman, M. N. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab387 · Cited by 197
Metadata
- Authors
- Patil, A., Goldust, M., & Wollina, U.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2022-01-19
- Volume
- 14
- Issue
- 2
- Pages
- 192
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W4205658817
- Cited by
- 454
- References
- 53
- FWCI
- 55.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Herpes zoster: A Review of Clinical Manifestations and Management. https://app.cochat.ai/papers/10.3390/v14020192
- The paper
- Patil, A., Goldust, M., & Wollina, U. (2022). Herpes zoster: A Review of Clinical Manifestations and Management. Viruses. https://doi.org/10.3390/v14020192
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.